JFA
AEGR

JNBA Financial Advisors’s Aegerion Pharmaceuticals AEGR Stock Holding History

JNBA Financial Advisors’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-35
Closed – – 1729
2016
Q2 		$0 Hold
35
– – ﹤0.01% 569
2016
Q1 		$0 Hold
35
– – ﹤0.01% 577
2015
Q4 		$0 Hold
35
– – ﹤0.01% 565
2015
Q3 		$0 Hold
35
– – ﹤0.01% 558
2015
Q2 		$1K Hold
35
– – ﹤0.01% 516
2015
Q1 		$1K Hold
35
– – ﹤0.01% 522
2014
Q4 		$1K Sell
35
-10
-22% -$252 ﹤0.01% 536
2014
Q3 		$2K Hold
45
– – ﹤0.01% 547
2014
Q2 		$1K Hold
45
– – ﹤0.01% 497
2014
Q1 		$2K Hold
45
– – ﹤0.01% 447
2013
Q4 		$3K Buy
+45
New +$3.44K ﹤0.01% 389

Other funds holding AEGR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

JNBA Financial Advisors's AEGR Position: Q3 2016 in Review

JNBA Financial Advisors sold out of Aegerion Pharmaceuticals (AEGR) in Q3 2016, closing a stake of 35 shares.

JNBA Financial Advisors first reported a position in AEGR in Q4 2013 and held it in 11 quarters. The position peaked at $3K in Q4 2013. 58 funds tracked by Wall St. Rank hold AEGR as of Q3 2016.

  • JNBA Financial Advisors reported no remaining Aegerion Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • JNBA Financial Advisors sold 35 Aegerion Pharmaceuticals shares in Q3 2016.
  • JNBA Financial Advisors first reported a position in Aegerion Pharmaceuticals in Q4 2013 and held it in 11 quarters.
  • JNBA Financial Advisors's Aegerion Pharmaceuticals position peaked at $3K in Q4 2013.
  • 58 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q3 2016.

Based on JNBA Financial Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.